PATIENT ALERT: Information regarding Coronavirus (COVID-19).  

Clinical Research & Trials

Cancer Research at Virginia Oncology

Search results for GYN Cancer Research

GYN Cancer Research

  • USO 20225

    A Phase 2, Multicenter, Single-Arm, Open-Label Study To Evaluate The Efficacy And Safety Of AK104 In Subjects With Recurrent Or Metastatic Cervical Cancer (AK104-201-AU) STAR

    Available at 3 locations

    View Details

  • USO 19221

    A Randomised, Multicentre, Double-blind, Placebo-controlled, Phase III Study of First-line Carboplatin and Pa;clitaxel in Combination with Durvalumab, Followed by Maintenance Durvalumab with or without Olaparib in Patients with Newly Diagnosed Advanced or Recurrent Endometrial Cancer (DUO-E) (D9311C00001;GOG-3041; ENGOT-EN10)

    Available at 2 locations

    View Details

  • USO 18269

    Pivotal, Randomized, Open-Label Study of Tumor Treating Fields (TTFields, 200kHz) Concomitant with Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer ( ENGOT-ov50 / INNOVATE-3)

    Available at 1 location

    View Details

  • USO 17218

    A Randomized, Double-Blind, Phase 3 Comparison Of Platinum-Based Therapy With TSR-042 And Niraparib Versus Standard Of Care Platinum-Based Therapy As First-Line Treatment Of Stage III or IV Nonmucinous Epithelial Ovarian Cancer (3000-03-005/ENGOT-OV44)

    Available at 5 locations

    View Details

  • USO 18232

    A Phase 1/1b Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants with Breast or Gynecologic Malignancies (AB928CSP0002)

    Available at 1 location

    View Details

  • USO 17182

    Clovis A Multicenter, Randomized, Double-Blind, Placebo Controlled Phase 3 Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy (ClovisCO-338-087/GOG-3020/ENGOT-ov45/NCRI/ATHENA)

    Available at 3 locations

    View Details